|
|
 |
|
|
|
|
27. B. Tiusanen. In The Management of Pharmaceutical R&D: The Keys to Success. D. Harnden and D. Macarthur, Eds. PJB Publications, Ltd., New York, 1990, p. 3132. |
|
|
|
|
|
|
|
|
28. D. Jack. In The Management of Pharmaceutical R&D: The Keys to Success. D. Harnden and D. Macarthur, Eds. PJB Publications, Ltd., New York, 1990, p. 106. |
|
|
|
|
|
|
|
|
29. W. K. Brandt and M. Ingold. From Medicines to Markets. Pharmaceutical Executive 14: 48, 1994. |
|
|
|
|
|
|
|
|
30. D. W. Johnson and A.A. Sinkula. Pharmaceuticals as Information. Pharmaceutical Executive 14: 52, 1994. |
|
|
|
|
|
|
|
|
31. P. R. Nayak and J. M. Ketteringham. Breakthroughs! Rawson Associates, New York, 1986. |
|
|
|
|
|
|
|
|
32. S. Osono. In The Management of Pharmaceutical R&D: The Keys to Success. D. Harnden and D. Macarthur, Eds. PJB Publications, Ltd., New York, 1990, p. 119. |
|
|
|
|
|
|
|
|
33. Y. Kishida. In The Management of Pharmaceutical R&D: The Keys to Success. D. Harnden and D. Macarthur, Eds. PJB Publications, Ltd., New York, 1990, p. 119. |
|
|
|
|
|
|
|
|
34. O. Harari. The Thomas Lawson Syndrome. Management Review: 58, Feb. 1994A. |
|
|
|
|
|
|
|
|
35. C. Cronrath, R. Eckel, and U. Abshagen. Portfolio Analysis: A Valuable Tool for Focusing R&D. Pharmaceutical Executive 13: 84, 1993. |
|
|
|
|
|
|
|
|
36. B. Spilker. Multinational Pharmaceutical Companies: Principles and Practices, 2nd ed. Raven Press, New York, 1994. |
|
|
|
|
|
|
|
|
37. M. R. Monk and M. Smith. Product Portfolio Analysis: SmithKline to SmithKline Beecham. J. Pharm. Marketing and Management 4: 85, 1990. |
|
|
|
|
|